These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them. Lansang MC; Hustak LK Cleve Clin J Med; 2011 Nov; 78(11):748-56. PubMed ID: 22049542 [TBL] [Abstract][Full Text] [Related]
4. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects. Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG J Am Acad Dermatol; 2017 Jan; 76(1):11-16. PubMed ID: 27986133 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid-induced adrenal suppression: physiological basis and strategies for glucocorticoid weaning. Bacchi S; Tan S; Slee M Med J Aust; 2024 Jun; 220(10):539. PubMed ID: 38714488 [No Abstract] [Full Text] [Related]
6. Glucocorticoid-induced adrenal suppression: physiological basis and strategies for glucocorticoid weaning. Torpy DJ; Lim WT Med J Aust; 2024 Jun; 220(10):539. PubMed ID: 38714501 [No Abstract] [Full Text] [Related]
9. Neurologic complications of corticosteroid therapy. Aita JA Postgrad Med; 1974 Feb; 55(2):111-5. PubMed ID: 4359080 [No Abstract] [Full Text] [Related]
10. Glucocorticoid-induced diabetes mellitus is a risk for vertebral fracture during glucocorticoid treatment. Tatsuno I; Sugiyama T Diabetes Res Clin Pract; 2011 Jul; 93(1):e18-20. PubMed ID: 21440321 [TBL] [Abstract][Full Text] [Related]
11. Current smoking is an independent risk factor for new-onset diabetes mellitus during highdose glucocorticoid treatment. Sugiyama T; Sugimoto T; Suzuki S; Sato Y; Tanaka T; Tatsuno I Int J Clin Pharmacol Ther; 2015 Aug; 53(8):616-20. PubMed ID: 25997545 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy. Kuperman H; Damiani D; Chrousos GP; Dichtchekenian V; Manna TD; Filho VO; Setian N J Clin Endocrinol Metab; 2001 Jul; 86(7):2993-6. PubMed ID: 11443157 [TBL] [Abstract][Full Text] [Related]
13. Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases. Huber BM; Bolt IB; Sauvain MJ; Flück CE Acta Paediatr; 2010 Dec; 99(12):1889-93. PubMed ID: 20649769 [TBL] [Abstract][Full Text] [Related]
15. [Complications in glucocorticoid treatment]. Kuralesin MG Med Sestra; 1981 Feb; 40(2):48-50. PubMed ID: 6907646 [No Abstract] [Full Text] [Related]
16. [Steroidogenic diabetes mellitus as a complication of glucocorticoid therapy of virus hepatitis]. Boroń P; Borzuchowska A; Modzelewski T Pol Arch Med Wewn; 1970 Feb; 44(2):103-7. PubMed ID: 5442934 [No Abstract] [Full Text] [Related]
17. Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent. Tobin AM; Barragry J; Kirby B; O'Shea L Ir Med J; 2005 Apr; 98(4):118. PubMed ID: 15938560 [No Abstract] [Full Text] [Related]
18. [The pathological anatomy of pemphigus in connection with its treatment with steroid hormones]. Vasil'eva NN Arkh Patol; 1968; 30(6):45-51. PubMed ID: 4301202 [No Abstract] [Full Text] [Related]
19. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Jasani MK; Boyle JA; Greig WR; Dalakos TG; Browning MC; Thompson A; Buchanan WW Q J Med; 1967 Jul; 36(143):261-76. PubMed ID: 6049762 [No Abstract] [Full Text] [Related]